Respiratory diseases and disorders are related to improper functioning or conditions of lungs and airway that can affect human respiratory process. Respiratory disposable devices are care devices that can aid in removal of mucus from airway, thus, improving pulmonary function. The different respiratory devices commercially available include tubes, face masks, filters, inhalers, and other related devices.
“US Respiratory Disposable Devices Market (by Device Type, and Application) Forecast: 2020 to 2029” – a recently created and published report by analysts at Market.us. The US respiratory disposable devices market was valued at US$ 0.5 Billion in 2019. The US market is projected to reach a value of around US$ 1 Billion in 2029, and register a compound annual growth rate of 7.5% over the 10-year forecast period.
Driver and Restraints: US Respiratory Disposable Devices Market
Inclining prevalence of various respiratory diseases and disorders such as COPD, asthma, etc. at a globe scale, and need for proper treatment to the patients are among the major factors expected to drive market growth over the 10-year forecast period. For instance, as per the Global Burden of Disease Study, 2016 reports revealed prevalence of 251 million cases of COPD. In addition, over 90% of deaths due to COPD occurred in middle and low-income countries. The number of cases of COPD is expected to increase further owing to the cigarette smoking and increasing geriatric population. Rapid industrialization is leading to increase in indoor and outdoor air pollution levels, as well as unhealthy diet, and physical inactivity are some of the other major factors that can potentially cause respiratory diseases.
Increasing number of government initiatives along with healthcare organizations, to reach large patient base and, spread awareness regarding the disorders and availability of treatment is another key factor expected to propel market growth. The NAEPP (National Asthma Education and Prevention Program) coordinated by the National Heart, Lung, and Blood Institute, addresses the increasing number of cases of asthma, develops clinical practice guidelines and other supportive materials based on the latest scientific evidence. To ensure effective control of asthma, it encourages partnerships among physicians, patients, and other healthcare professionals through education programs and modern treatment. In addition, Global Initiative for Chronic Obstructive Lung Disease engages in organizing events with COPD patients and health care providers at a global level, in order to spread awareness regarding COPD, with an objective to enhance COPD care to patients globally.
Segment and Region Snapshot: US Respiratory Disposable Devices Market
By Device Type: The tubes segment is expected to account for majority revenue share and is projected to register highest CAGR over the 10-year forecast period. The face masks segment is estimated to follow the tubes segment in terms of revenue share and growth rate. By Application: The adult segment is estimated to account for majority revenue share in the target market and is projected to register steady growth.
Key Players profiled in the report:
1. Becton Dickinson and Company
2. Medline Industries Inc.
3. Teleflex Incorporated
4. Armstrong Medical Industries Inc.
5. Westmed Inc.
6. Dynarex Corporation
7. Respironics Inc.
8. ResMed Inc.
9. Invacare Corporation
10. Allied Healthcare Products Inc.